Technical Analysis for BIOC - Biocept, Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Strong | Down | Up | Up |
| See historical BIOC trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Jan 18 | Boomer Buy Setup | Bullish Swing Setup | 0.00% |
| Jan 18 | Volume Surge | Other | 0.00% |
| Jan 18 | Calm After Storm | Range Contraction | 0.00% |
| Jan 18 | Parabolic Rise | Strength | 0.00% |
| Jan 18 | Upper Bollinger Band Walk | Strength | 0.00% |
| Jan 18 | Inside Day | Range Contraction | 0.00% |
| Jan 18 | Wide Bands | Range Expansion | 0.00% |
| Jan 18 | Upper Bollinger Band Touch | Strength | 0.00% |
| Jan 17 | Pocket Pivot | Bullish Swing Setup | -24.42% |
| Jan 17 | Volume Surge | Other | -24.42% |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2018-11-08
- Sector: Healthcare
- Industry: Diagnostic & Testing Substances
Biocept, Inc., a cancer diagnostics company, is engaged in the development and commercialization of proprietary circulating tumor cell (CTC) and circulating tumor DNA tests. The company's tests provide information to oncologists that enable them to select the appropriate treatment for their patients based on detailed data on the characteristics of tumors. Its tests include OncoCEE-BR, a breast cancer CTC test that allows physician to characterize the tumor to help define treatment options. The company sells its products through its sales force and partners that focus on selling directly to community oncologists in hospitals, cancer centers, and offices in the United States. Biocept, Inc. was founded in 1997 and is headquartered in San Diego, California.
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more BIOC news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 19.2 |
| 52 Week Low | 0.66 |
| Average Volume | 1,810,818 |
| 200-Day Moving Average | 4.0037 |
| 50-Day Moving Average | 1.2908 |
| 20-Day Moving Average | 1.2344 |
| 10-Day Moving Average | 1.6055 |
| Average True Range | 0.5428 |
| ADX | 33.99 |
| +DI | 36.9277 |
| -DI | 3.5439 |
| Chandelier Exit (Long, 3 ATRs ) | 2.0916 |
| Chandelier Exit (Short, 3 ATRs ) | 2.3284 |
| Upper Bollinger Band | 2.55 |
| Lower Bollinger Band | -0.0812 |
| Percent B (%b) | 0.9 |
| BandWidth | 213.156189 |
| MACD Line | 0.3053 |
| MACD Signal Line | 0.0892 |
| MACD Histogram | 0.2161 |
| Fundamentals | Value |
|---|---|
| Market Cap | 69.29 Million |
| Num Shares | 30.3 Million |
| EPS | -1.06 |
| Price-to-Earnings (P/E) Ratio | -2.16 |
| Price-to-Sales | 5.54 |
| Price-to-Book | 3.79 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.12 | ||||
| Resistance 3 (R3) | 3.18 | 2.97 | 2.98 | ||
| Resistance 2 (R2) | 2.97 | 2.76 | 2.94 | 2.93 | |
| Resistance 1 (R1) | 2.63 | 2.63 | 2.53 | 2.57 | 2.89 |
| Pivot Point | 2.42 | 2.42 | 2.37 | 2.39 | 2.42 |
| Support 1 (S1) | 2.08 | 2.21 | 1.98 | 2.02 | 1.69 |
| Support 2 (S2) | 1.87 | 2.08 | 1.84 | 1.65 | |
| Support 3 (S3) | 1.53 | 1.87 | 1.60 | ||
| Support 4 (S4) | 1.47 |
